Hasmukh Chudgar profile photo

Hasmukh Chudgar

Global rank #457 · Healthcare
Estimated net worth
$8.45B
$0 (0.00%) since the previous Grizzly Bulls update
Updated Nov 3, 2026, 7:21 PM EST

Profile details

Residence and biographical details are shown from cited sources. Time-sensitive facts are withheld when their supporting evidence is no longer current.

Residence
Ahmedabad, India
Current source dated Mar 10, 2026 · Verified Sep 7, 2026

Hasmukh Chudgar built his fortune by founding Intas Pharmaceuticals in 1977 and growing it into an international generics and biopharmaceutical company before handing day-to-day operations to his sons. [1][2]

He founded the pharmaceutical business behind the family fortune

Forbes says Hasmukh Chudgar founded generics maker Intas Pharmaceuticals in 1977, making company creation rather than inheritance the starting point of the fortune. [1]

Forbes says Chudgar later handed operating responsibility to his sons Nimish and Binish, who run the company, while a third son, Urmish, heads its biopharma business. [1]

That succession places the present fortune within a family-run enterprise, but the reviewed evidence traces the original operating asset and its creation to Hasmukh Chudgar himself. [1]

Intas expanded into a global pharmaceutical platform

Forbes describes Intas as a multibillion-dollar revenue pharmaceutical company whose major markets include Europe and India and notes continued expansion through acquisitions. [1]

Intas says it now operates across more than 85 countries through a vertically integrated pharmaceutical business and a network of international subsidiaries, supporting the scale built from the company Chudgar founded. [2]

Sources for background

Sources reviewed Sep 24, 2026.

  1. Hasmukh Chudgar & family · Forbes · Mar 10, 2026
  2. About Us · Intas Pharmaceuticals

Comparable Healthcare billionaires

Similar Healthcare billionaires by estimated net worth.

Sources and calculations

Grizzly Bulls tracks this published net worth estimate over time and separately values identified public holdings when share counts and market prices are available. The total shown at the top currently uses the latest available Forbes estimate; holding values shown on this page do not replace it.

Background citations are listed with the background section so its numbered references remain easy to follow.